Proteins

product description：A cell-permeable piperidinyl-pyridine compound that acts as a selective inhibitor of IKK-2 activity (IC50 = 8.5 and 250 nM for IKK-2 and IKK-1, respectively) with little effect towards IKK-3, Syk, and MKK4 (IC50 &gt:20 µM).

product description：A cell-permeable piperidinyl-pyridine compound that acts as a selective inhibitor of IKK-2 activity (IC50 = 8.5 and 250 nM for IKK-2 and IKK-1, respectively) with little effect towards IKK-3, Syk, and MKK4 (IC50 &gt:20 µM).

Acr-Bis.

Acridine Yellow G.

Acridine Yellow G.

Acridine Yellow G.

Acridine Yellow G.

Actoxumab (anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab (anti-Cdiff Toxin A) prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile.

Actoxumab (anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab (anti-Cdiff Toxin A) prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile.

Actoxumab (anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab (anti-Cdiff Toxin A) prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile.

Actoxumab (anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab (anti-Cdiff Toxin A) prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile.

Acylase from Aspergilus sp.